Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to Q2 2021 webcast

Zalaris ASA will release its second quarter 2021 results on Thursday 26 August 2021.Zalaris will host a webcast for all shareholders and interested parties on 26 August at 08:30 CET. There will be a Q&A session following the management presentation. Link to webcast will be available on ir.zalaris.com.   Contact: Gunnar Manum, CFOMobil: +47 95 17 91 90 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Metso Outotec and Ascendum Makina to cooperate in Turkey

Metso Outotec Corporation’s press release on August 19, 2021, at 11:00 a.m. EESTMetso Outotec and Ascendum Makina Tic A.S. have started the cooperation to provide crushing and screening solutions for companies in the aggregate industry in Turkey. As of August 2021, Ascendum will sell Metso Outotec’s mobile and stationary crushers,  vibrating equipment, and track- and wheel-mounted crushers and screens for aggregate processing. In addition, Ascendum will provide related Metso Outotec’s crusher wear parts and provide services, such as commissioning, service contracts and technical support.

ADDvise strengthens the management team, recruits COO

ADDvise strengthens its Group management and recruits Fredrik Mella as COO. Fredrik has extensive international experience in the Medtech industry and has held key positions such as CEO, sales manager, COO and board member.Fredriks most recent position was the CEO of ScandiNova, a world leading company in pulsed power and microwave systems that was within the MedTech Industry and Research. He has previously been the Export Director at ETAC AB, which develops, manufactures, and sells medical devices. Board member of Abilia, a Medtech company that is part of the MedCap group. Fredrik has an

SBB to arrange Capital Markets Day on 10 September 2021 in Skellefteå

Samhällsbyggnadsbolaget i Norden AB (”SBB”) invites investors, analysts and media to a capital markets day in Sara Kulturhus in Skellefteå on Friday 10 September 2021 at 9:30 CEST. The CMD will also be available to follow through a webcast. SBB’s Founder and CEO Ilija Batljan and other key individuals will hold presentations, focusing on the company’s strategy and objectives going forward. A full invitation with practical information will be announced shortly. For further information, please contact:Marika Dimming, Investor Relations, ir@sbbnorden.se

3 x Red Dot to HiQ

HiQ with its design team from Great Apes wins two Red Dot and one Best of the Best for two projects in this years Red Dot Design Awards. With Lux Nemus, an interactive projection experience and a part of Metsä Group’s visitor center, Pro Nemus, HiQ’s Great Apes wins Best of the Best: Interface & User Experience Design and Spatial Communication: Light Installations. The Levi Resort app wins Interface & User Experience Design: Mobile User Interfaces. – Fantastic work from Great Apes. That many of their projects keep winning so many awards is proof of the high level of execution from the team,

Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in HusCompagniet's shares

Company announcement 16/2021 Pursuant to the Market Abuse Regulation article 19, HusCompagniet A/S, CVR no. 36972963 ("HusCompagniet" or the “Company”), shall hereby notify receipt of information of the following transactions made by persons discharging managerial responsibilities in HusCompagniet and persons closely associated with them in HusCompagniet's shares and other financial instruments linked thereto. 1 Details of the Reporting Person and their Closely Associated Personsa) Name Diego Holding Guernsey Limited2 Reason for the

FLNG – Key information relating to the dividend for the second quarter, 2021

Key information relating to the dividend to be paid by Flex LNG Ltd. for the second quarter 2021: Dividend amount: $0.40 Declared currency: USD Last day including right: 31 August, 2021 Ex-date: 1 September, 2021 Record date: 2 September, 2021 Payment date: On or about 16 September, 2021 Date of approval: 16 August, 2021 This information is published in accordance with the requirements of the Continuing Obligations.

Wärtsilä power plant will support export growth and job creation in Bangladeshi Export Processing Zone

Wärtsilä Corporation, Trade press release, 19 August 2021 at 10.30 AM EESTThe technology group Wärtsilä will supply a 40 MW power plant to provide a reliable and efficient electricity supply to an Export Processing Zone (EPZ) in Bangladesh. The plant is expected to encourage industrial investments in the zone, which in turn will create employment and future growth for the area. The plant has been ordered by Sigma Powertech, and will be located in Adamjee EPZ, close to Dhaka, the capital of Bangladesh. The contract with Wärtsilä comprises orders placed in Q1 and Q2, 2021. “This is an

NENT Group names Nobel documentary ‘The Prize of Silence’ its next Viaplay Original

· English- and Swedish-language series explores sexual abuse scandal that led to Nobel Prize postponement · ‘The Prize of Silence’ is executive produced by ‘Surviving R. Kelly’ executive producer Joel Karsberg · NENT Group to premiere at least 50 original productions in 2021 ‘The Prize of Silence’, a powerful English- and Swedish-language documentary series about the sexual abuse scandal that engulfed the Swedish Academy and led to the postponement of the 2018 Nobel Prize in Literature, will be the next Viaplay Original from Nordic Entertainment Group (NENT Group). Executive

NOTICE TO ATTEND EXTRAORDINARY GENERAL MEETING IN SCIBASE HOLDING AB (PUBL)

The shareholders of SciBase (publ), reg.no 556773-4768 (the "Company") are hereby summoned to an extraordinary general meeting on Tuesday 7 September 2021.The board of directors has, in light of continued spread of the coronavirus and in accordance with the Swedish Act (2020:198) on temporary exceptions to facilitate the execution of general meetings in companies and other associations, decided that the extraordinary general meeting shall be held without physical presence of shareholders, proxies and/or external parties and that the shareholders shall have only the opportunity to vote by

Brighter's Subsidiary Nectarine Health Enters into an Agreement in & Expands Friendly User Trial with Solutionology Health in the U.S.

Brighter AB (publ) announced today that its subsidiary, Nectarine Health, has entered into an agreement and expanded its Friendly User Trials with Solutionology Health, a leading reimbursement specialist, to gain market access and insights for the company’s AI driven home care system for the elderly in the U.S. Solutionology Health is a U.S.-based healthcare specialist with a deep understanding of the reimbursement process for private insurance providers and Medicare in the U.S. In the agreement, Solutionology Health will bring additional users to the ongoing Friendly User Trials in

Brazilian terminal orders three new Konecranes Generation 6 Mobile Harbor Cranes to increase capacity, competitiveness

· Contract marks first order for new, revamped Konecranes Gottwald’s mobile harbor crane portfolio · New Generation 6 is engineered for electric power and can run on battery power, cutting fuel and maintenance costs and helping customers meet their low-carbon targets Konecranes has won an order to deliver three of its new eco-efficient Generation 6 Konecranes Gottwald cranes to Super Terminais Comercio e Industria Ltda (Super Terminais) in Brazil. The order, booked in June 2021, makes Super Terminais the first customer for the new cranes, and will help it sustainably meet growing

SciBase nominating committee proposes the election of Dr Jvalini Dwarkasing as a new Board member

STOCKHOLM, SWEDEN, — August 19, 2021 – SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that the Nominating Committee proposes the election of Dr. Jvalini Dwarkasing as a new Board member at an extraordinary general meeting to be proposed by the Board of Directors of SciBase.The nominating committee, consisting of Christer Jönsson (appointed by FourierTransorm), Iraj Arastoupour, Peter Elmvik and Tord Lendau Chairman of the Board, hereby proposes the election of Dr. Jvalini Dwarkasing as a new member

SRV to renew historic property in Kamppi – construction of Kulttuurikasarmi begins

SRV GROUP PLC     INVESTOR NEWS      2021 19 AUGUST    10:00 EET SRV to renew historic property in Kamppi – construction of Kulttuurikasarmi begins SRV and Föreningen Konstsamfundet r.f. have signed an agreement to build a unique entertainment centre called Kulttuurikasarmi, in Lasipalatsi Square in the Kamppi district of Helsinki. The project involves a basic renovation of Helsinki’s former bus station, and the existing building will also be extended with both underground areas and a glass pavilion to be built in Narinkka Square. The parties’ joint investment in the project will

ENDOMINES Half-year interim report 2021 Restart of the Friday Mine in Idaho – USA and Pampalo Mine - Finland

Endomines AB, Stock Exchange Release 19 August 2021 at 09:00 CESTH1 2021 (vs. H1 2020) Operational highlights · Endomines ends the Care and Maintenance phase at the Friday Mine in Idaho, USA by upgrading the Orogrande Processing facility and continuing development work at the mine. · Endomines prepares for the restart of its Pampalo Mine, Finland in 2022 with the decline development progressing at a rate of 80m per month from the 775m RL and infill drilling for grade control purposes down to the 805m RL. · Endomines signs a merger plan and decides on the re-domiciliation of

Fiskars Group investing in Digital & IT capabilities

Fiskars CorporationPress releaseAugust 19, 2021 at 10:00 EEST  Fiskars Group investing in Digital & IT capabilities Fiskars Group is focusing on creating organic growth in the longer term. A strong digital business is a pre-requisite for growth and while the company has invested in this field, it is committed to doing more.The company’s clear digital ambition entails building strong capabilities within data, direct to consumer and consumer experience online. “Data is increasingly important for Fiskars Group as it plays an essential role in everything, and we need to be

EOS Russia - Half year report 1 January - 30 June 2021

· The loss for EOS during the period was SEK -21.7 million (-174.6). Loss per share was SEK -0.63 (-4.75). Total comprehensive income for the period was SEK 3.8 million (-165.6). · EOS recorded a net loss from investing activities of SEK -15.9 million (-167.9) comprising net dividends of SEK 19.9 million and a negative development in the investment portfolio of SEK -35.8 million. · Operating expenses amounted to SEK -5.8 million (-6.4).  · Net financial items for the period amounted to SEK -0.0 million (-0.4).  · EOS’ net asset value at June 30, 2021 was SEK 647 million (739).

Interim Report Second Quarter 2021

NASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENOSTENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2021 – 30.06.2021. The report is attached to this release and is also available on https://stenocare.com/investor-relations/ Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: “Q2 brought clarity to the future of the medical cannabis industry in Denmark. The Danish Pilot Programme for treatment of patients was extended with another four-years, and cultivation/production is permanently legal. This is very good news for both patients and for the

Cantargia publishes half year report

Cantargia AB’s (”Cantargia”) half year report for the period January until June 2021 is now available on the company’s web page www.cantargia.com/en/investors/financial-reports.Significant events in the second quarter · Preclinical results for the CAN10 antibody were presented at the IMMUNOLOGY2021 conference. · A letter of intent was signed with GEICAM to conduct a clinical study with nadunolimab in combination with carboplatin/gemcitabine in triple negative breast cancer. · Positive interim results were presented from the CANFOUR study showing an improved progression-free

ExpreS2ion announces financial results for the second quarter of 2021

Hørsholm, Denmark, August 19, 2021 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its second quarter financial results for 2021. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.CEO Bent U. Frandsen comments “During the second quarter of 2021, we reported on continued progress in key pipeline areas for ExpreS[2]ion including COVID-19, breast cancer and malaria, while also securing 39 MSEK in additional funding from the exercise of warrants of series TO4. I want to start this CEO comment with

MEDIVIR AB – INTERIM REPORT JANUARY – JUNE 2021

Positive study results for MIV-818 and remetinostat. Design determined for the combination study with MIV-818April – JuneFinancial summary for the quarter · Net turnover amounted to SEK 0.9 (4.0) million. · The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -17.1 (-12.4) million. Basic and diluted earnings per share amounted to SEK -0.35 (-0.52) and SEK -0.35 (-0.52) respectively. · Cash flow from operating activities amounted to SEK -21.9 (-23.3) million. · Liquid assets and short-term investments at the end of the period amounted to SEK

Scandion Oncology A/S announces its results for the first half year of 2021

Scandion Oncology today announces its half year report for 2021. The following is taken from the report. Bo Rode Hansen, President and CEO comments “Positive interim CORIST results highlight an intensive quarter - The second quarter of 2021 was as busy and rewarding as the first three months. We reached several milestones both clinically and organizationally. Most importantly, we reported positive interim results from our Phase IIclinical study CORIST.” Key figures & highlights TDKK Q2 2021 Q2 2020 Q1-Q2 2021 Q1-Q2 2020 2020 Net sales

Interim report Jan-June 2021

Clinics build experienceSecond Quarter 2021 · Revenue amounted to SEK 411 (6,263) thousand, of which SEK 383 (5,787) thousand were capitalized costs. · Loss after tax amounted to SEK-18,263 (-5,516) thousand. · Loss per share SEK -0.30 (-0.18). · Cash and cash equivalents amounted to SEK 48,339 (7,177) thousand. First half of 2021 · Revenues amounted to SEK 816 (12,531) thousand, of which SEK 762 (12,090) thousand capitalized costs. · Cash flow from operating activities amounted to SEK -23,999 (-13,107) thousand. · Profit after tax amounted to SEK -35,519 (-12,

There are no items matching the current filter
There are no more items matching the current filter
Back to top